James Ford
Impact in
- Physiology top 5%
- Tuberous Sclerosis Complex Research
- Histiocytic Disorders and Treatments
-
- Polyomavirus and related diseases
- Vascular Tumors and Angiosarcomas
Papers in
-
- Melanoma and MAPK Pathways 4
- Protein Degradation and Inhibitors 3
-
- Click Chemistry and Applications 3
- Co-authors
- Tarek Sahmoud (1 shared paper)Michael Kohrman (1 shared paper)Elizabeth A. Thiele (1 shared paper)Joyce Y. Wu (1 shared paper)E. Martina Bebin (1 shared paper)Petrus J. de Vries (1 shared paper)Sergiusz Jóźwiak (2 shared papers)Rachel Kuperman (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)The American Journal of Gastroenterology (1 paper)Annals of Oncology (1 paper)Cancer Research (1 paper)The Lancet (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
James Ford
7 papers receiving 611 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Physiology 385
- Oncology 203
- Genetics 68
- Neurology 74
- Pulmonary and Respiratory Medicine 119
Countries citing papers authored by James Ford
This map shows the geographic impact of James Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Ford more than expected).
Fields of papers citing papers by James Ford
This network shows the impact of papers produced by James Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Ford. The network helps show where James Ford may publish in the future.
Co-authors
The 25 scholars most cited alongside James Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial Hit paper breakdown → | 2012 | 578 |
| 2 | 2016 | 24 | |
| 3 | 2014 | 7 | |
| 4 | 2014 | 4 | |
| 5 | 2012 | 2 | |
| 6 | 2015 | 1 | |
| 7 | 2015 | 1 |
About James Ford
James Ford is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Physiology and Pathology and Forensic Medicine, having authored 7 papers that have together received 617 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), Protein Degradation and Inhibitors (3 papers), Click Chemistry and Applications (3 papers), Tuberous Sclerosis Complex Research (2 papers), Colorectal Cancer Treatments and Studies (1 paper), BRCA gene mutations in cancer (1 paper), Genetic factors in colorectal cancer (1 paper) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Physiology (385 citations), Oncology (203 citations), Genetics (68 citations), Neurology (74 citations) and Pulmonary and Respiratory Medicine (119 citations). James Ford has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Tarek Sahmoud, Michael Kohrman, Elizabeth A. Thiele, Joyce Y. Wu, E. Martina Bebin, Petrus J. de Vries, Sergiusz Jóźwiak, Rachel Kuperman, David Lebwohl and Gaurav Shah. Their work appears in journals such as Journal of Clinical Oncology, The American Journal of Gastroenterology, Annals of Oncology, Cancer Research and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.